Evidence map›Paper›PMID 42769619›Full record

ArticleRSC advances2026

Mild-condition green synthesis of manganese nanoparticles for next-generation broad-spectrum antibacterial applications.

Sameera Sh Mohammed Ameen, Chinar M Mohammed, Jassim Mohammed Abdo, Mohammed A Hami, Thamer M Bashir, Khalid M Omer

Abstract read
In one paragraph

Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sameera Sh Mohammed AmeenDepartment of Chemistry, College of Science, University of Zakho Zakho Kurdistan region 42002 Iraq.ORCID https://orcid.org/0009-0002-3990-5328
Chinar M MohammedDepartment of Biology, College of Science, University of Zakho Zakho Kurdistan region 42002 Iraq.
Jassim Mohammed AbdoDepartment of Biomedical Science, College of Medicine, University of Zakho Zakho 42002 Kurdistan Reign Iraq.
Mohammed A HamiDepartment of Chemistry, College of Science, University of Zakho Zakho Kurdistan region 42002 Iraq.
Thamer M BashirDepartment of Biology, College of Science, University of Zakho Zakho Kurdistan region 42002 Iraq.
Khalid M OmerDepartment of Chemistry, College of Science, University of Sulaimani Sulaymaniyah Kurdistan region 46002 Iraq khalid.omer@univsul.edu.iq.ORCID https://orcid.org/0000-0002-6866-4116

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Environmentally benign fabrication of metal nanoparticles has gained considerable attention as a substitute for traditional physical and chemical synthesis methods due to its operational simplicity, low production cost, reduced environmental impact, and compatibility with biomedical applications. In this work, manganese nanoparticles (Mn NPs) were produced through a plant-mediated approach in which the plant extract functioned simultaneously as a reducing and capping agent. The synthesis was carried out under gentle reaction conditions without relying on hazardous reagents or energy-intensive procedures, emphasizing the green and sustainable character of the method. The resulting Mn NPs were thoroughly characterized using a range of analytical techniques that verified their successful formation, nanoscale dimensions, homogeneous morphology, and satisfactory colloidal stability. Their antibacterial performance was subsequently evaluated against selected Gram-positive and Gram-negative bacterial strains. The Mn NPs demonstrated strong antimicrobial activity by generating distinct inhibition zones against all tested bacteria. Among the bacterial isolates,

Identifiers

PMID42769619
PMCPMC13592092

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.